Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Marinus Finds Silver Lining In Ganaxolone Trial Miss

Executive Summary

The biotech announces another poor performance for its lead drug candidate, but puts a positive spin on the data and plans continued development.

Advertisement

Related Content

Marinus Nixes Ganaxolone Indication After Trial Fail

Topics

Advertisement
UsernamePublicRestriction

Register